Methylphenidate in Early Poststroke Recovery


Phase 2 Results

Eligibility Criteria

Inclusion Criteria

Stroke of any kind, based on clinical history, neurologist evaluation, and computed tomography (CT).

Exclusion Criteria

Childbearing potential, hypersensitivity to methylphenidate, significant psychosis, glaucoma, Tourette disorder, motor tics, uncontrolled epilepsy, malignant hypertension, prominent agitation, or current antidepressant treatment.